Cited by 76Pancreatic function and diabetesDiabetes Management and ResearchDiabetes Treatment and Management

A High Concentration of Circulating Insulin Suppresses the Glucagon Response to Hypoglycemia in Normal Man*

LlU, DATING, MOBERG, ERIK, KOLLIND, MAGNUS, LINS, PER-ERIC, ADAMSON, ULF·1991·The Journal of Clinical Endocrinology & Metabolism

Abstract

In an attempt to clarify whether circulating insulin per se exerts an inhibitory effect on the hormonal responses to hypoglycemia, with special emphasis on glucagon secretion, nine healthy volunteers were exposed to low dose (244 pmol/kg.h) and high dose (1034 pmol/kg.h) iv insulin infusions for 3 h on two separate occasions. A close to identical arterial hypoglycemia of about 3.4 mmo/L was obtained in both tests by glucose clamping during the high dose test. The corresponding glucose concentration in the venous blood was significantly lower in the high dose test (2.5 +/- 0.1 vs. 3.0 +/- 0.1 mmol/L; P less than 0.01), while the plasma free insulin level was 4 times higher in the high dose test (897 +/- 50 vs. 208 +/- 14 pmol/L). Plasma glucagon was elevated in both experiments, but its rise was reduced during the high dose test after 1 h, yielding an incremental area under the glucagon curve that was significantly smaller than that obtained during the low dose test (213 +/- 70 vs. 348 +/- 81 ng/L.h; P less than 0.05). The plasma adrenaline, noradrenaline, GH, C-peptide, pancreatic polypeptide, and somatostatin profiles were similar in the two tests. We conclude that an inhibitory effect of circulating insulin on the glucagon response to hypoglycemia can be demonstrated in normal man during an infusion of insulin yielding a plasma concentration of about 900 pmol/L. The responses of other hormones studied are not significantly influenced by the circulating insulin level.

Integrity signals

Registry

Crossref · 10.1210/jcem-73-5-1123

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the hypoglycaemic range, the arteriovenous difference is small (probably less than 0.2 mmol/l), but it can be influenced considerably by the level and duration of hyperinsulinaemia.

    “In the hypoglycaemic range the arteriovenous difference is small (probably less than 0.2 mmol/l), but it can be influenced considerably by the level and duration of hyperinsulinaemia [8].”

    From Defining hypoglycaemia: what level has clinical relevance? (2009) · cites this paper as [8]

  • Evidence exists in nondiabetic and type 1 diabetic subjects to implicate hyperinsulinemia per se in suppressing the release of glucagon in response to hypoglycemia while increasing catecholamine and cortisol release, although this has been disputed.

    “Evidence exists in nondiabetic and type 1 diabetic subjects to implicate hyperinsulinemia per se in suppressing the release of glucagon in response to hypoglycemia (43-46) while increasing catecholamine and cortisol release (47), although this has been disputed (48).”

    From Hypoglycemia in Type 2 Diabetes (2005) · cites this paper as [45]

The citation lists haven’t been fetched yet

References 34 · Cited by 76

Authors
LlU, D., MOBERG, E., KOLLIND, M., LINS, P.-E., & ADAMSON, U.
Affiliations
Danderyds sjukhus (SE)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1991-11
Volume
73
Issue
5
Pages
1123-1128
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2058969843
Cited by
76
References
34
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2017: 1 · 2015: 1 · 2013: 2 · 2012: 1
FWCI
6.78
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
insulin, glucagon, hypoglycemia, insulin-glucagon interaction, insulin infusion, epinephrine, norepinephrine, growth hormone, C-peptide, pancreatic polypeptide, somatostatin
MeSH terms
Adult, Blood Glucose, C-Peptide, Epinephrine, Female, Glucagon, Humans, Hypoglycemia, Infusions, Intravenous, Insulin, Kinetics, Male, Norepinephrine, Pancreatic Polypeptide, Somatostatin, Growth Hormone, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review